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LETTERS TO THE EDITOR
Selection or Work-Up
Bias: A Recurrent
Caveat in Evaluation of
New Diagnostic
Modalities
To the Editor:
I read with great interest the recent
manuscript by Ernst et al. on the compar-
ison of endobronchial ultrasound (EBUS)
versus mediastinoscopy (MS) and the
accompanying editorial.1,2 The authors
report a sensitivity of 87% for EBUS ver-
sus 68% for cervical MS and conclude
that “endobronchial ultrasound may be
preferred in the histologic sampling of
paratracheal and subcarinal mediastinal
adenopathy because the diagnostic yield
can surpass mediastinoscopy.”
The recently introduced minimally
invasive staging procedures—endoscopic
esophageal ultrasound and EBUS—repre-
sent promising staging and restaging
techniques for lung cancer although
their specific role in relation to invasive
techniques remains controversial and
has not been clearly established yet. Un-
fortunately, when these newer diagnos-
tic procedures are compared with the
more classic techniques as cervical MS,
certain biases repeatedly show-up in
most studies which lead to inaccurate
conclusions.3 Also the present study
clearly suffers from a so-called work-up
or selection bias where a new technique
is only applied in a specific, predefined
subset of patients in whom the diagnos-
tic yield is known to be very high. Pa-
tients evaluated for lung cancer were
first selected by computed tomography
scan, which is rather inaccurate for pri-
mary staging, and only patients with
enlarged lymph nodes in some specific
stations were included. The newer tech-
nique—EBUS—was only applied in
these pathologically enlarged lymph
nodes and only these stations were com-
pared with MS. No information is pro-
vided on the other lymph node stations
sampled at MS which were not evalu-
ated by EBUS; so, the reported sensitiv-
ity of EBUS is artificially high. More-
over, as in a previous comparative study,
only suboptimal results are present for
cervical MS.4,5 The latter study con-
cluded that esophageal ultrasound was
superior to MS, but sensitivity of MS
was only 24%. Although this study was
published in 2005, no further prospec-
tive studies were published confirming
these results. In a prospective study
from our institution comparing MS with
the findings on chest computed tomog-
raphy published in 1997, sensitivity of
cervical MS was 89% and for the sub-
carinal lymph node station seven, where
the largest disagreement was noted by
Ernst et al., sensitivity was 87%. Even
for repeat MS, sensitivity has been re-
ported to be higher than for the pri-
mary MS in the present study. Four
centers participated in this trial includ-
ing a total of 66 patients. There were
only three endoscopists performing
EBUS versus eight surgeons perform-
ing MS. In the methods section only a
very short paragraph is dedicated to
MS. What was the experience of the
surgeons performing MS? Were they
all thoracic surgeons? Were specific
guidelines followed? What are the overall
results for routine MS in each participat-
ing center? In fact, EBUS results in a
selected group of patients are com-
pared with a suboptimal performed
cervical MS, questioning the final
conclusion.
From its introduction MS has
been constantly criticized by radiolo-
gists, nuclear and invasive pulmonary
physicians. However, by providing
large tissue samples and a complete
mapping of the superior mediastinum,
it remains an invaluable tool for stag-
ing and restaging of lung cancer. The
value of minimally invasive techniques
still has to be demonstrated in prospective
studies with a clear design in which selec-
tion biases that artificially raise sensitivity,
are eliminated. The beginning of the end
of MS seems far away . . .
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To the Editor:
Histopathologic diagnosis is criti-
cal for lung cancer treatment, but some-
times it could be challenging when the
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